QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 专题：吉林大学白求恩第一医院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study 期刊论文 LANCET DIABETES & ENDOCRINOLOGY, 2018, 卷号: 6, 期号: 8 作者:  Zhao, Guiyu;  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua 收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05 Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naive Chinese patients: Analysis of results from the CONSENT trial 期刊论文 DIABETES OBESITY & METABOLISM, 2018, 卷号: 20, 期号: 4 作者:  Ji, Linong;  Liu, Jing;  Yang, Jing;  Li, Yufeng;  Liang, Li 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05 metformin  type 2 diabetes   Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 期刊论文 DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 卷号: 33 作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 期刊论文 DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 卷号: 33 作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm Process 期刊论文 CLINICAL PHARMACOKINETICS, 2017, 卷号: 56, 期号: 8 作者:  Liu, Dongyang;  Zhang, Yi;  Jiang, Ji;  Choi, John;  Li, Xuening 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Clinical observations of beta cell function improvement in Chinese T2D patients who underwent 4 weeks of treatment with HMS5552, a novel Glucokinase activator 期刊论文 DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 卷号: 31 作者:  Ding, Yanhua;  Hu, Pei;  Zhu, Dalong;  Li, Xiaoying;  Li, Yongguo 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Clinically differentiated glucokinase activator HMS5552: effective control of 24-hour glucose and improvement of beta cell function in T2DM patients 期刊论文 DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 卷号: 31 作者:  Zhu, Dalong;  Ding, Yanhua;  Xiao, Dawei;  Fan, Hongwei;  Hu, Pei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Clinically differentiated glucokinase activator HMS5552: effective control of 24-hour glucose and improvement of beta cell function in T2DM patients 会议论文 作者:  Zhu, Dalong 收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05 Clinical observations of beta cell function improvement in Chinese T2D patients who underwent 4 weeks of treatment with HMS5552, a novel Glucokinase activator 期刊论文 DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 卷号: 31 作者:  Ding, Yanhua;  Hu, Pei;  Zhu, Dalong;  Li, Xiaoying;  Li, Yongguo 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05